InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by PALMISANO ROBERT J, Director. Director active across 2 companies, notably RxSight, Inc.. In total, 8 reports have been published. History available since 3 August 2021. The latest transaction was disclosed on 31 August 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
8 of 8 declarations
Robert J. Palmisano serves as a Board Member of RxSight, Inc. He brings valuable expertise to the board with his in-depth knowledge of the medical sector. Robert plays a key role in overseeing operations and making strategic decisions to ensure the company's success.